2025년 Immuno-Oncology Summit에서 주요 파마·혁신적 바이오테크놀러지 프레젠테이션

업계 파이오니어, 사고 리더, 인플루언서에 의한 프레젠테이션에서는 암면역의 최신 브레이크스루를 소개합니다.

---

Engineering Antibody-Drug Conjugates for Optimal Payload Delivery in Solid Tumors
Ian Nessler, PhD, Senior Scientist II, Quantitative, Translational, and ADME Sciences, AbbVie

Functional Effects of Cancer Cell Phagocytosis on Tumor Macrophages
Kristin V. Tarbell, PhD, Associate Director, Discovery, Amgen

Women in Science Meet-Up
Amina Metidji, PhD, Senior Scientist, AstraZeneca

Advancing Drug Discovery with Hypoxic 3D Tumor Models
Orna Rabinovich Ernst, PhD, Senior Scientist, R&D, AstraZeneca

Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T Cell Exclusion in Human Lung Tumors
Shilpa Keerthivasan, PhD, Associate Director, Immunology, Bristol Myers Squibb

Comparison of Cancer-Targeting and Stromal-Targeting Antibody-Drug Conjugates Using Bystander Quantitative Systems Pharmacology Models
Ezgi Wood, PhD, Associate Director, QSP, Bristol Myers Squibb

Impacts of ADCs on the Immune Response to Cancer
Ryan A. Heiser, PhD, Director Immuno-Oncology, Pfizer

* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.